Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/54595
Campo DC Valoridioma
dc.contributor.authorA-González, Noelia
dc.contributor.authorCastrillo, Antonio
dc.date.accessioned2019-02-18T11:49:43Z-
dc.date.available2019-02-18T11:49:43Z-
dc.date.issued2011
dc.identifier.issn0925-4439
dc.identifier.urihttp://hdl.handle.net/10553/54595-
dc.description.abstractThe liver X receptors (LXR alpha and LXR beta) are members of the nuclear receptor family of transcription factors that play essential roles in the transcriptional control of lipid metabolism. LXRs are endogenously activated by modified forms of cholesterol known as oxysterols and control the expression of genes important for cholesterol uptake, efflux, transport, and excretion in multiple tissues. In addition to their role as cholesterol sensors, a number of studies have implicated LXRs in the modulation of innate and adaptive immune responses. Both through activation and repression mechanisms, LXRs regulate diverse aspects of inflammatory gene expression in macrophages. The ability of LXRs to coordinate metabolic and immune responses constitutes an attractive therapeutic target for the treatment of chronic inflammatory disorders. This article is part of a Special Issue entitled: Translating nuclear receptors from health to disease. (C) 2011 Elsevier B.V. All rights reserved.
dc.publisher0925-4439
dc.relation.ispartofBiochimica et Biophysica Acta - Molecular Basis of Disease
dc.sourceBiochimica et Biophysica Acta - Molecular Basis of Disease[ISSN 0925-4439],v. 1812, p. 982-994
dc.subject.otherOrphan Nuclear Receptors
dc.subject.otherPhospholipid Transfer Protein
dc.subject.otherEndoplasmic-Reticulum Stress
dc.subject.otherApoptotic Cell Clearance
dc.subject.otherAbcg1(-/-) Bone-Marrow
dc.subject.otherAcid-Binding Protein
dc.subject.otherNf-Kappa-B
dc.subject.otherLxr-Alpha
dc.subject.otherPpar-Gamma
dc.subject.otherGene-Expression
dc.titleLiver X receptors as regulators of macrophage inflammatory and metabolic pathways
dc.typeinfo:eu-repo/semantics/review
dc.typeArticle
dc.identifier.doi10.1016/j.bbadis.2010.12.015
dc.identifier.scopus79958763372
dc.identifier.isi000292350400021
dc.contributor.authorscopusid28567533000
dc.contributor.authorscopusid55445301000
dc.description.lastpage994
dc.description.firstpage982
dc.relation.volume1812
dc.type2Reseña
dc.contributor.daisngid34354606
dc.contributor.daisngid225640
dc.contributor.wosstandardWOS:A-Gonzalez, N
dc.contributor.wosstandardWOS:Castrillo, A
dc.date.coverdateAgosto 2011
dc.identifier.ulpgces
dc.description.sjr2,488
dc.description.jcr5,387
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0002-2057-2159-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameCastrillo Viguera,Antonio Jesús-
Colección:Reseña
Vista resumida

Citas SCOPUSTM   

102
actualizado el 14-abr-2024

Citas de WEB OF SCIENCETM
Citations

96
actualizado el 25-feb-2024

Visitas

21
actualizado el 09-mar-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.